Cooperative Agreement U01DE036113
- The University of Southern California (USC) received a $828,538 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "MICRORNA THERAPY TARGETING FIBROTIC SCAR FORMATION FOR IMPROVEMENT OF COGNITIVE FUNCTION AFTER TRAUMATIC BRAIN INJURY". The award has a performance period from May 1, 2024 to April 30, 2027. The funded research aims to develop novel microRNA-based therapies to address fibrotic...
- The University of Southern California (USC) has been awarded a $1,092,695 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on August 1, 2025, will support the establishment of the Convergent Science Virtual Cancer Center, with a performance period extending through July 31, 2029. This federally funded research initiative aims to transform healthcare for military service members, veterans, and the broader...
- The University of Southern California (USC) was awarded a $3,296,634.00 Project Grant from the Defense Health Agency to conduct research on "ACTIVATION OF BRAIN LYMPHATIC DRAINAGE THROUGH PIEZO1-CONTROLLED MECHANOTRANSDUCTION AS A NOVEL HYDROCEPHALUS THERAPY". The grant, which commenced on September 1, 2023 and will be completed by August 31, 2027, is funded through the Military Medical Research and Development (CFDA 12.420) program. This research aims to investigate medical...
- The U.S. Department of Defense (DoD) awarded a $100,000 Cooperative Agreement under the Basic, Applied, and Advanced Research in Science and Engineering program (CFDA 12.630) to the University of Southern California (USC) on August 5, 2024. The funding supports a range of scientific research and technological development initiatives at USC that contribute to national defense missions while maintaining potential civilian applications. USC, a leading private research university, will leverage...
- The University of Southern California (USC) Department of Contracts and Grants Division was awarded a $331,630 Project Grant by the Defense Health Agency under the "Military Medical Research and Development" (CFDA 12.420) program. The grant supports research into mRNA delivery for polycystic kidney disease, with a period of performance from November 15, 2023 to November 14, 2025. As a leading private research university, USC leverages its expertise in engineering, health sciences,...
- The Department of Defense awarded a $3,166,177 Cooperative Agreement to the University of Southern California (USC) under the Military Medical Research and Development program (CFDA 12.420) on September 30, 2023. This funding supports the "Convergent Science Cancer Consortium" project, which aims to transform healthcare for Service Members and the American public through innovative biomedical research on cancer and other disease areas. As part of this effort, USC has sub-awarded...
- The University of Pittsburgh was awarded a $400,000 Cooperative Agreement under the Trans-NIH Research Support program (CFDA 93.310) by the National Institutes of Health (NIH) with a start date of September 9, 2025 and an ultimate completion date of June 30, 2030. The award will fund the Collaborative for Research to Advance TMD Evidence (CREATE) project, which aims to address critical gaps in the understanding of temporomandibular disorders (TMDs) through a bidirectional approach integrating...
- The University of Southern California (USC) was awarded a $690,340 federal Project Grant by the National Institute of Dental and Craniofacial Research (NIDCR), which administers the Oral Diseases and Disorders Research (CFDA 93.121) program. The grant, awarded on April 10, 2025, supports research to study active transcellular and intracellular phosphate movements and their impact on enamel mineralization processes during dental development. The project aims to leverage five unique mouse models...
- The University of Southern California will receive $1,209,550 under a three-year Project Grant award from the Department of the Army Medical Command. The grant falls under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to improve health care for service members and the public. Specifically, USC will develop wearable early intervention electric stimulation technology for optic nerve regeneration. The...
- The University of Southern California will receive $330,000 under a two-year Project Grant award from the Department of the Army Medical Command. The grant falls under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to improve military and public health care. Through this funding, USC will validate PIKFYVE inhibition as a therapeutic approach for diverse forms of frontotemporal dementia from March 2021 to...
The University of Southern California (USC) was awarded a $100,000.00 Cooperative Agreement on September 11, 2025 by the Department of Health and Human Services National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310). The award, titled "BROADER EVALUATION OF TMD TREATMENT EFFICACY AND RESPONSE (BETTER TMD)", supports research on Temporomandibular Disorders (TMD) treatment efficacy and response. As a leading academic research institution, USC will leverage its extensive expertise across biomedical and healthcare domains to conduct this multi-year project, with a planned completion date of June 30, 2030. The award reflects USC's strong capabilities in delivering complex, high-impact research initiatives to federal agencies through mechanisms such as cooperative agreements and indefinite delivery contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $100.0k | 9/11/25 |